CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,772 | -41.4% | 3,187,699 | -10.6% | 0.00% | -40.0% |
| Q2 2023 | $37,138 | +39.7% | 3,564,026 | -6.6% | 0.01% | +25.0% |
| Q1 2023 | $26,583 | +695.9% | 3,813,896 | +588.6% | 0.00% | +300.0% |
| Q4 2022 | $3,340 | -100.0% | 553,865 | +22.9% | 0.00% | 0.0% |
| Q1 2022 | $8,837,000 | -48.9% | 450,642 | -10.6% | 0.00% | -50.0% |
| Q4 2021 | $17,297,000 | -34.5% | 504,148 | +4.3% | 0.00% | 0.0% |
| Q3 2021 | $26,402,000 | +11582.3% | 483,371 | +15624.5% | 0.00% | – |
| Q2 2021 | $226,000 | -99.8% | 3,074 | -99.8% | 0.00% | -100.0% |
| Q1 2021 | $125,308,000 | +21.9% | 1,370,088 | +8.1% | 0.01% | +18.2% |
| Q4 2020 | $102,780,000 | +83.6% | 1,267,798 | +5.4% | 0.01% | +83.3% |
| Q3 2020 | $55,973,000 | – | 1,202,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |